TAMs, by activating the STAT3 signaling in HCC cells, are associated with large tumor size, intrahepatic metastasis, and a high rate of HCC recurrence (Peng et al., 2005; Mano et al., 2013). Here, STAT3 is linked to hepatocellular carcinoma.